Castle Biosciences CSTL
NASDAQ CSTL
$34.74 -0.25 (-0.70%)
As of: Sep 22, 2026 · 10:48 AM EDT

Castle Biosciences (CSTL) Liabilities and Shareholders Equity (2018 - 2026)

Castle Biosciences' (CSTL) quarterly Liabilities and Shareholders Equity came in at $561.2 million in Q2 2026, up 3.02% year-over-year from $544.7 million in Q2 2025, and up 2.44% quarter-over-quarter from $547.8 million in Q1 2026.

Analysis

Castle Biosciences (CSTL) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

Castle Biosciences has disclosed Liabilities and Shareholders Equity across 9 years of filings, most recently posting $561.2 million for Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity rose 3.02% year-over-year to $561.2 million; the TTM figure through Jun 2026 stood at $2.3 billion (up 7.56% YoY), while the FY2025 annual figure was $578.6 million, up 8.91% from the prior year.
  • Liabilities and Shareholders Equity came in at $561.2 million for Q2 2026 at Castle Biosciences, up from $547.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $578.6 million in Q4 2025 to a low of $425.4 million in Q2 2023.
  • Average Liabilities and Shareholders Equity over 5 years is $491.0 million, with a median of $472.9 million recorded in 2024.
  • Year-over-year, Liabilities and Shareholders Equity decreased 7.19% in 2023 and gained 18.01% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $447.3 million in 2022, then gained by 1.34% to $453.3 million in 2023, then climbed by 17.18% to $531.2 million in 2024, then rose by 8.91% to $578.6 million in 2025, then slipped by 3.0% to $561.2 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $561.2 million in Q2 2026, $547.8 million in Q1 2026, and $578.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 2.66 Bn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 16.94 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 18.53 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 1.91 Bn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 2.37 Bn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 1.23 Bn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 3.31 Bn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 729.70 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 640.68 Mn
10 Castle Biosciences 1.08 Bn 811.36 Mn 79.85 Mn 561.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 561.18 Mn
Mar 31, 2026 547.81 Mn
Dec 31, 2025 578.56 Mn
Sep 30, 2025 562.79 Mn
Jun 30, 2025 544.73 Mn
Mar 31, 2025 501.72 Mn
Dec 31, 2024 531.24 Mn
Sep 30, 2024 514.57 Mn
Jun 30, 2024 487.31 Mn
Mar 31, 2024 458.51 Mn
Dec 31, 2023 453.34 Mn
Sep 30, 2023 436.02 Mn
Jun 30, 2023 425.40 Mn
Mar 31, 2023 426.89 Mn
Dec 31, 2022 447.33 Mn
Sep 30, 2022 457.81 Mn
Jun 30, 2022 458.38 Mn
Mar 31, 2022 444.43 Mn
Dec 31, 2021 462.57 Mn
Sep 30, 2021 433.69 Mn
API Access

Castle Biosciences Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CSTL&period=max&api_key=YOUR_API_KEY